First Heartland Consultants Inc. decreased its holdings in shares of Express Scripts Holding Company (NASDAQ:ESRX) by 6.3% in the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 20,056 shares of the company’s stock after selling 1,341 shares during the period. First Heartland Consultants Inc.’s holdings in Express Scripts were worth $1,270,000 as of its most recent filing with the Securities and Exchange Commission.

Several other large investors have also bought and sold shares of the company. Burt Wealth Advisors lifted its stake in Express Scripts by 11.4% during the second quarter. Burt Wealth Advisors now owns 1,696 shares of the company’s stock valued at $108,000 after buying an additional 174 shares in the last quarter. CKW Financial Group lifted its stake in Express Scripts by 20.0% during the second quarter. CKW Financial Group now owns 1,800 shares of the company’s stock valued at $115,000 after buying an additional 300 shares in the last quarter. Bank of Nova Scotia Trust Co. purchased a new stake in Express Scripts during the third quarter valued at about $120,000. First Personal Financial Services lifted its stake in Express Scripts by 199.1% during the second quarter. First Personal Financial Services now owns 2,103 shares of the company’s stock valued at $134,000 after buying an additional 1,400 shares in the last quarter. Finally, Financial Management Professionals Inc. lifted its stake in Express Scripts by 140.1% during the second quarter. Financial Management Professionals Inc. now owns 2,334 shares of the company’s stock valued at $149,000 after buying an additional 1,362 shares in the last quarter. Institutional investors own 88.44% of the company’s stock.

In other Express Scripts news, VP Phyllis S. Anderson sold 643 shares of the stock in a transaction that occurred on Wednesday, November 1st. The stock was sold at an average price of $62.37, for a total transaction of $40,103.91. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, CEO Timothy C. Wentworth purchased 8,000 shares of the stock in a transaction on Tuesday, October 31st. The shares were bought at an average price of $61.13 per share, for a total transaction of $489,040.00. Following the acquisition, the chief executive officer now owns 98,628 shares of the company’s stock, valued at $6,029,129.64. The disclosure for this purchase can be found here. 0.68% of the stock is currently owned by company insiders.

Express Scripts Holding Company (ESRX) opened at $68.39 on Tuesday. The firm has a market cap of $38,598.32, a P/E ratio of 9.96, a P/E/G ratio of 1.01 and a beta of 0.88. The company has a current ratio of 0.73, a quick ratio of 0.61 and a debt-to-equity ratio of 0.86. Express Scripts Holding Company has a 52-week low of $55.80 and a 52-week high of $73.52.

Express Scripts (NASDAQ:ESRX) last issued its quarterly earnings data on Tuesday, October 24th. The company reported $1.90 earnings per share for the quarter, meeting the consensus estimate of $1.90. The firm had revenue of $24.68 billion for the quarter, compared to analyst estimates of $25.68 billion. Express Scripts had a net margin of 3.64% and a return on equity of 25.46%. The company’s revenue for the quarter was down 2.9% on a year-over-year basis. During the same quarter last year, the firm earned $1.74 earnings per share. equities analysts expect that Express Scripts Holding Company will post 7.01 EPS for the current year.

A number of research firms have commented on ESRX. Robert W. Baird reaffirmed a “hold” rating and set a $56.00 price objective on shares of Express Scripts in a research note on Friday, September 1st. Jefferies Group reaffirmed a “buy” rating on shares of Express Scripts in a research note on Thursday, October 26th. Zacks Investment Research raised shares of Express Scripts from a “hold” rating to a “buy” rating and set a $64.00 price objective for the company in a research note on Monday, October 16th. Sanford C. Bernstein raised shares of Express Scripts from an “underperform” rating to a “market perform” rating in a research note on Wednesday, December 6th. Finally, ValuEngine lowered shares of Express Scripts from a “buy” rating to a “hold” rating in a research note on Friday, September 1st. Six research analysts have rated the stock with a sell rating, eleven have assigned a hold rating, seven have assigned a buy rating and one has given a strong buy rating to the company’s stock. The stock currently has an average rating of “Hold” and an average price target of $70.67.

TRADEMARK VIOLATION WARNING: “First Heartland Consultants Inc. Trims Stake in Express Scripts Holding Company (ESRX)” was published by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are accessing this article on another website, it was stolen and republished in violation of US and international trademark & copyright legislation. The correct version of this article can be read at https://www.thecerbatgem.com/2017/12/12/first-heartland-consultants-inc-trims-stake-in-express-scripts-holding-company-esrx.html.

Express Scripts Profile

Express Scripts, Inc is a pharmacy benefit management (PBM) company in North America, offering a range of services to its clients, which include health insurers, third-party administrators, employers, union-sponsored benefit plans, workers’ compensation plans and government health programs. It operates in two segments: PBM and Emerging Markets (EM).

Institutional Ownership by Quarter for Express Scripts (NASDAQ:ESRX)

Receive News & Stock Ratings for Express Scripts Holding Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Express Scripts Holding Company and related stocks with our FREE daily email newsletter.